v3.25.4
Consolidated Statement Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income (loss) including noncontrolling interests $ 29,764 $ 35,063 $ 37,354
Adjustments for noncash transactions      
Depreciation and depletion (includes impairments) 25,993 23,442 20,641
Deferred income tax charges/(credits) 765 (865) 634
Postretirement benefits expense in excess of/(less than) net payments (64) (358) 90
Other long-term obligation provisions in excess of/(less than) payments (1,430) (1,712) (1,501)
Dividends received greater than/(less than) equity in current earnings of equity companies 3,006 191 509
Changes in operational working capital, excluding cash and debt      
Notes and accounts receivable reduction/(increase) (3,042) (6,030) 4,370
Inventories reduction/(increase) (4,300) (1,812) (3,472)
Other current assets reduction/(increase) (164) 389 (426)
Accounts and other payables increase/(reduction) (222) 5,627 (4,727)
Net (gain)/loss on asset sales (1,113) (1,223) (513)
All other items - net 2,777 2,310 2,410
Net cash provided by operating activities 51,970 55,022 55,369
CASH FLOWS FROM INVESTING ACTIVITIES      
Additions to property, plant, and equipment (28,358) (24,306) (21,919)
Proceeds from asset sales and returns of investments 3,158 4,987 4,078
Additional investments and advances (4,133) (3,299) (2,995)
Other investing activities including collection of advances 3,406 1,926 1,562
Cash acquired from mergers and acquisitions 0 754 0
Net cash used in investing activities (25,927) (19,938) (19,274)
CASH FLOWS FROM FINANCING ACTIVITIES      
Additions to long-term debt 2,311 899 939 [1]
Reductions in long-term debt (1,108) (1,150) (15)
Additions to short-term debt [3] 2,359 [2] 0 0
Reductions in short-term debt [3] (5,404) (4,743) (879)
Additions/(reductions) in commercial paper, and debt with three months or less maturity 1,895 (18) (284)
Contingent consideration payments (79) (27) (68)
Cash dividends to ExxonMobil shareholders (17,231) (16,704) (14,941)
Cash dividends to noncontrolling interests (935) (658) (531)
Changes in noncontrolling interests (704) (791) (894)
Inflows from noncontrolling interests for major projects 88 32 124
Common stock acquired (20,273) (19,629) (17,748)
Net cash provided by (used in) financing activities (39,081) (42,789) (34,297)
Effects of exchange rate changes on cash 532 (676) 105
Increase/(decrease) in cash and cash equivalents (including restricted) (12,506) (8,381) 1,903
Cash and cash equivalents at beginning of year (including restricted) 23,187 31,568 29,665
Cash and cash equivalents at end of year (including restricted) $ 10,681 $ 23,187 $ 31,568
[1]
(1) Includes $568 million issued to facilitate the sale of an entity where the buyer assumed the debt upon closing; no longer on the Consolidated Balance Sheet at the end of 2023.
[2]
(2) Includes $659 million of proceeds related to a financing arrangement to facilitate the sale of an entity where the buyer assumed the obligation at closing; no longer on the Consolidated Balance Sheet at the end of 2025.
[3]
(3) Includes commercial paper with a maturity greater than three months.

Source